Erkek Osteoporozu
Osteoporoz kemik mineral yoğunluğunda azalma ve kemik kırılganlığında artış ile
seyreden metabolik bir kemik hastalığıdır. Beklenen yaşam süresinin uzaması osteoporozu
ciddi bir morbidite ve mortalite nedeni haline getirmektedir.
___
- 1. Willson T, Nelson SD, Newbold J, Nelson RE, LaFleur J. The
clinical epidemiyology of male osteoporosis: a review of the
recent literature. Clinical Epidemiyology 2015:7 65-76.
- 2. Sutton R AL, Dian L, Guy P. Osteoporosis in men: an underrecognized
and undertreated problem. BC Medical Journal.
2011: 53 no: 10
- 3. Rosen CJ, Kurland ES, Vereault D et al. Association between
serum insülin growth factor-1 (IGF-1) and a simple sequence
repeat in IGF-1 gene: implications for genetic studies of
bone mineral density. J Clin Endocrinol Metab 1998; 83: 2286-
2290
- 4. Van Pottelbergh I, Goemaere S, Zmierczak H, Kaufman JM,
Perturbed sex steroid status in men with idiopathic osteoporosis
and their sons. J Clin Endocrinol Metab 2004; 89: 2286-
2290
- 5. Adler AA. Osteoporosis in men: a review. Bone research 2014:2
14001
- 6. Ryan CS, Petkov VI, Adler RA. Osteoporosis in men: the value
of laboratory testing. Osteoporosis Int 2011;22:1845-1853
- 7. Fitzpatrick LA. Secondary causes of osteoporosis. Mayo Clin
Proc 2012;77: 453-468
- 8. Orwoll E, Nielson CM, Marshall LM, et al. Vitamin D deficiency
in older men. J Clin Endocrinol Metab 2009;94:1214-
22.
- 9. Papaioannou A,Morin S, Cheung AM et al. 2010 clinical practice
guidelines fort he diagnosis and management of osteoporosis
in Canada: Summary CMAJ 2010;182:1864-73
- 10. Orwoll E, Ettinger M,Weiss S et al. Alendronate for the treatment
of osteoporosis in men. N Eng J Med 2000;343:604-10
- 11. Nayak S, Greesspan S. Osteoporosis treatment efficacy for men:
a systematic review and meta-analysis. Journal of American
Geriatrics Society 2016
- 12. Schoofs MW, van der Klift M, Hofman A et al. Thiazide diüretics
and the risk for hip fracture. Ann Intern Med
2003;139:476-82.
- 13. Kaufman JM, Audran G, Bianchi G, Braga M et al.Efficacy
and safety of strontium ranelate in the treatment of osteoporosis
in men. J Clini Endoc Metab 2013 Vol 98.
- 14. Smith MR, Egerdie B, Hernandez TN, et al. Denosumab in men
receiving androgen-deprivation therapy for prostate cancer.
N Eng J Med 2009;361:745-755